The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.
Orphan drug sales have nearly doubled since 2008, a trend set to continue through 2022 as biopharma companies increasingly focus on meds to treat a variety of rare diseases. Sales for the super-pricey drug class will nearly double—again—by...
No need to be worried Los Angeles residents, Clippers owner and former CEO of Microsoft Corporation (NASDAQ: MSFT), Steve Ballmer, is taking care of the bill for the Clippers new arena.
"We are expanding that investment by entering into an...
The U.S. Supreme Court's unanimous backing on Monday of a ruling by the country's top patent court was a rare instance of agreement with a body whose decisions in that specialized area it regularly overturns.
'Dangal' is in rare territory as it racks up over $1 million per weekend day so far into its run. By the time it reached this point in its run last year, 'Zootopia' was doing about a third less revenue per day than 'Dangal' is now.
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.